Novel small RNAs expressed by Bartonella bacilliformis under multiple conditions reveal potential mechanisms for persistence in the sand fly vector and human host.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
11 2020
Historique:
received: 28 07 2020
accepted: 06 10 2020
revised: 04 12 2020
pubmed: 21 11 2020
medline: 26 1 2021
entrez: 20 11 2020
Statut: epublish

Résumé

Bartonella bacilliformis, the etiological agent of Carrión's disease, is a Gram-negative, facultative intracellular alphaproteobacterium. Carrión's disease is an emerging but neglected tropical illness endemic to Peru, Colombia, and Ecuador. B. bacilliformis is spread between humans through the bite of female phlebotomine sand flies. As a result, the pathogen encounters significant and repeated environmental shifts during its life cycle, including changes in pH and temperature. In most bacteria, small non-coding RNAs (sRNAs) serve as effectors that may post-transcriptionally regulate the stress response to such changes. However, sRNAs have not been characterized in B. bacilliformis, to date. We therefore performed total RNA-sequencing analyses on B. bacilliformis grown in vitro then shifted to one of ten distinct conditions that simulate various environments encountered by the pathogen during its life cycle. From this, we identified 160 sRNAs significantly expressed under at least one of the conditions tested. sRNAs included the highly-conserved tmRNA, 6S RNA, RNase P RNA component, SRP RNA component, ffH leader RNA, and the alphaproteobacterial sRNAs αr45 and speF leader RNA. In addition, 153 other potential sRNAs of unknown function were discovered. Northern blot analysis was used to confirm the expression of eight novel sRNAs. We also characterized a Bartonella bacilliformis group I intron (BbgpI) that disrupts an un-annotated tRNACCUArg gene and determined that the intron splices in vivo and self-splices in vitro. Furthermore, we demonstrated the molecular targeting of Bartonella bacilliformis small RNA 9 (BbsR9) to transcripts of the ftsH, nuoF, and gcvT genes, in vitro.

Identifiants

pubmed: 33216745
doi: 10.1371/journal.pntd.0008671
pii: PNTD-D-20-01331
pmc: PMC7717549
doi:

Substances chimiques

RNA, Bacterial 0
RNA, Small Untranslated 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008671

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI128575
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Am J Trop Med Hyg. 1968 Jul;17(4):503-15
pubmed: 4876803
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4620-5
pubmed: 11917098
Infect Immun. 1993 Dec;61(12):4962-71
pubmed: 8225570
Infect Immun. 2000 Jul;68(7):4102-7
pubmed: 10858227
Gene. 2019 Aug 5;708:38-48
pubmed: 31128223
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2919
pubmed: 25032975
Am J Pathol. 1990 May;136(5):1125-35
pubmed: 1693472
Am J Trop Med Hyg. 2018 Nov;99(5):1229-1233
pubmed: 30226144
Infect Immun. 1986 Nov;54(2):347-53
pubmed: 3770946
Exp Parasitol. 1998 Nov;90(3):212-9
pubmed: 9806865
Methods Mol Biol. 2019;1962:1-14
pubmed: 31020551
BMC Microbiol. 2010 Mar 06;10:71
pubmed: 20205931
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Bioinformatics. 2008 Jun 15;24(12):1461-2
pubmed: 18441000
Microb Pathog. 2020 Oct;147:104272
pubmed: 32464301
Clin Dermatol. 2009 May-Jun;27(3):271-80
pubmed: 19362689
Rev Inst Med Trop Sao Paulo. 1993 Nov-Dec;35(6):485-90
pubmed: 7997750
Am J Trop Med Hyg. 1999 May;60(5):799-805
pubmed: 10344656
Bioinformatics. 2012 Feb 15;28(4):464-9
pubmed: 22199388
Emerg Infect Dis. 2013 Jul;19(7):1111-4
pubmed: 23764047
J Bacteriol. 1998 Mar;180(5):1174-84
pubmed: 9495756
Bioinformatics. 2010 Feb 15;26(4):493-500
pubmed: 20022975
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Microbiology (Reading). 2006 Jun;152(Pt 6):1751-1763
pubmed: 16735738
Am J Trop Med Hyg. 1990 Mar;42(3):215-21
pubmed: 2316791
N Engl J Med. 2007 Jun 7;356(23):2381-7
pubmed: 17554119
Infect Dis Poverty. 2016 Dec 1;5(1):105
pubmed: 27903286
Blood. 1961 May;17:562-78
pubmed: 13741078
PLoS Negl Trop Dis. 2020 Apr 17;14(4):e0008236
pubmed: 32302357
PLoS Pathog. 2009 Nov;5(11):e1000660
pubmed: 19915718
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nucleic Acids Res. 2008 Jun;36(10):3420-35
pubmed: 18445632
Infect Immun. 2003 Dec;71(12):6933-42
pubmed: 14638782
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W119-23
pubmed: 24838564
Proc Jpn Acad Ser B Phys Biol Sci. 2008;84(7):246-63
pubmed: 18941301
RNA Biol. 2012 Feb;9(2):119-29
pubmed: 22418845
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W124-9
pubmed: 24753424
Genome Biol. 2005;6(8):R70
pubmed: 16086852
Microbiol Spectr. 2018 May;6(3):
pubmed: 29916345
Cell Microbiol. 2002 Sep;4(9):557-69
pubmed: 12390349
Comp Med. 2008 Feb;58(1):76-80
pubmed: 19793460
Curr Opin Microbiol. 2016 Apr;30:133-138
pubmed: 26907610
Infect Immun. 1995 Apr;63(4):1552-62
pubmed: 7890422
Annu Rev Microbiol. 2018 Sep 08;72:141-161
pubmed: 30200848
Infect Immun. 2001 Jul;69(7):4373-81
pubmed: 11401976
IEEE Trans Vis Comput Graph. 2014 Dec;20(12):1983-92
pubmed: 26356912
Nature. 1992 May 14;357(6374):173-6
pubmed: 1579169
FEMS Microbiol Lett. 2000 Jan 1;182(1):119-24
pubmed: 10612742
J Exp Biol. 2008 Sep;211(Pt 17):2792-8
pubmed: 18723537
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
PLoS Negl Trop Dis. 2015 Oct 05;9(10):e0004128
pubmed: 26436553
Nucleic Acids Res. 2017 Jul 3;45(W1):W435-W439
pubmed: 28472523
J Bacteriol. 2019 Oct 21;201(22):
pubmed: 31451541
Microbiologyopen. 2017 Apr;6(2):
pubmed: 27790856
Infect Dis Clin North Am. 2000 Mar;14(1):1-22, vii
pubmed: 10738670
Biol Chem. 2017 May 1;398(5-6):625-635
pubmed: 28085670
Genome Biol Evol. 2016 Jun 14;8(6):1722-33
pubmed: 27189998
Annu Rev Biochem. 2003;72:209-47
pubmed: 14527323
Trends Microbiol. 2002 Nov;10(11):485-8
pubmed: 12419605
Mob DNA. 2014 Mar 10;5(1):8
pubmed: 24612670
Bioinformatics. 2017 Sep 15;33(18):2938-2940
pubmed: 28645171
EMBO J. 1996 Aug 1;15(15):3993-4000
pubmed: 8670904
J Bacteriol. 1999 Feb;181(3):1049-53
pubmed: 9922276
Front Cell Infect Microbiol. 2014 Oct 28;4:151
pubmed: 25389522
Am J Trop Med Hyg. 1997 Aug;57(2):174-9
pubmed: 9288812
Front Cell Infect Microbiol. 2016 Mar 08;6:24
pubmed: 27014636
Clin Infect Dis. 2001 Sep 15;33(6):772-9
pubmed: 11512081
Nature. 2012 Mar 28;484(7395):538-41
pubmed: 22456704

Auteurs

Shaun Wachter (S)

Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America.

Linda D Hicks (LD)

Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America.

Rahul Raghavan (R)

Department of Biology and Center for Life in Extreme Environments, Portland State University, Portland, Oregon, United States of America.

Michael F Minnick (MF)

Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH